SAT0227 The Efficacy of Vasoactive and Vasodilating Drugs on Digital Ulcers Healing in Systemic Sclerosis: Data from The Desscipher Observational Study of Eustar Group
Giuseppina Abignano(NIHR Leeds Musculoskeletal Biomedical Research Unit), Francesco Del Galdo(University of Leeds), Ulrich A. Walker(University Hospital of Basel), Svetlana I. Nihtyanova(Georgetown University), Dörte Huscher(Zimmer Biomet (Germany)), Marco Matucci‐Cerinic(Vita-Salute San Raffaele University), Jelena Blagojević(Leeds Teaching Hospitals NHS Trust), Serena Guiducci(Azienda Ospedaliero-Universitaria Careggi), Yannick Allanore(Inserm), Elise Siegert(Humboldt-Universität zu Berlin), Laura Cometi(University of Florence), Oliver Distler(University Hospital of Zurich), G. Riemekasten(Charité - Universitätsmedizin Berlin), Britta Maurer(University of Zurich), CP Denton(The Royal Free Hospital), Jérôme Avouac(Inserm), Veronika K. Jaeger, Gabriele Valentini(University of Campania "Luigi Vanvitelli"), Ulf Müller‐Ladner(Justus-Liebig-Universität Gießen), Serena Vettori, L. Czirják(University of Pecs), M. Frerix
Cited by 0
Related Papers
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
|Annals of the Rheumatic Diseases|2009|615
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503